Could 68Ga-PSMA PET/CT Evaluation Reduce the Number of Scheduled Prostate Biopsies in Men Enrolled in Active Surveillance Protocols?
Pietro PepeMarco RoscignoLudovica PepePaolo PanellaMarinella TamburoGiulia MarlettaFrancesco SavocaGiuseppe CandianoSebastiano CosentinoMassimo IppolitoAndreas TsirgiotisMichele PennisiPublished in: Journal of clinical medicine (2022)
68Ga-PSMA PET/CT did not improve the detection for csPCa of SPBx but would have spared 24/30 (80%) scheduled biopsies showing a lower false positive rate in comparison with mpMRI (20% vs. 43.3%) and a negative predictive value of 85.7% vs. 57.1%, respectively.